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Introduction
It is well-known that research and development (R&D) activities are difficult to finance externally given the nonrivalry feature of most innovations (c.f., Nelson, 1959; Arrow, 1962; Schumpeter, 1942) . This observation, together with the widely-held belief that R&D yields positive externalities, has been used to motivate external support and governments' tax incentives for R&D. Empirical findings, some of which we discuss below, also validate these support mechanisms.
The analysis in this paper expands the general understanding of R&D financing and incentives by identifying a theoretical reallocation of investment between R&D and non-R&D activities when borrowing spreads change. It finds that the direction and strength of the reallocation depends on R&D incentives. These incentives are of two types: external (both private and government) grants and subsidies, and tax credits. When incentives are mostly in the form of the former, an increase in funding costs prompts firms' to reallocate funds towards R&D activities.
These results are reversed when tax credits are the primary R&D incentive. In the second half of the paper, these relationships are tested and confirmed by using firm-level financial and sectorlevel R&D incentives data and a unique identification strategy that focuses on within firm allocation of investment. The findings indicate that firms increase their share of R&D activities in their total investment expenditures when funding costs rise, with the reallocation mechanism strongest for firms with a high degree of R&D activity. Consistent with theoretical predictions, incentives in the form of external grants and loans reinforce and tax incentives mitigate the reallocation of funds to R&D activities.
The implication of these findings is that funding-costs, in addition to their effects on aggregate investment, can affect the composition of investment, increasing the share of high-growth, high-technology activities when they rise for example. Given that these activities are associated with skilled-labor and that labor costs are the largest component of R&D spending, our findings also imply that changes in credit market conditions may change the composition of the labor market. Specifically, the presence of R&D activity increases the fluctuations of demand for unskilled labor that is prompted by changes in borrowing costs. Incentives that aim to increase the level of R&D activity also decrease the distortionary effects of this activity only if they are in the form of grants and loans. By contrast, tax incentives, the primary form of government support for R&D, amplify the distortionary effects on output and labor markets.
Our theoretical predictions come from a dynamic model that includes a generalized version of Romer (1990) type technology. Firms that use this technology accumulate stocks of both R&D and physical capital and they receive tax credit and loans/grants for R&D activities. Loans and grants decrease the firms' reliance on external funding and thus tightening credit conditions cause a disproportionate decline in their non-R&D investment (which is fully financed externally) and an increase in the share of R&D activity. In our model, higher levels of R&D tax credits skew the composition of investment towards R&D by lowering unit costs. These cost advantages, however, become relatively less important at higher interest rates. Firms that receive incentives mostly in the form of tax credit, therefore, experience a decrease in the share of their R&D activities when credit conditions tighten. Overall, we identify distortionary effects of R&D incentives on the investment allocation of firms. We predict that these effects may depend on the level of interest rates and the type of incentive, with external grants and loans disproportionately increasing and R&D tax credits decreasing the share of R&D during credit tightening.
In the first half of the paper, we also present a version of our model where R&D incentives affect firms' labor demand instead of investment. Distinguishing between skilled and unskilled labor, we find, naturally, that firms receiving higher degrees of incentives shift their composition of labor towards skilled work force that is the recipient of the incentives. More interestingly, we observe that these firms experience a sharper drop in the share of their skilled labor demand when the skilled-unskilled worker wage gap increases, compared to firms that are less-incentivized.
In the second half of the paper, we use firm level balance sheet data and sector level R&D incentives data to test some predictions from our model. Our firm level data are at the quarterly frequency, they are obtained from the COMPUSTAT database and they span the 2010Q1 -2015Q4 time period. This database provides observations for firms' R&D and non-R&D investment as well as others such as firms' liquidity, financial constraints and profitability. The types of variables we use in our investigation of investment behavior and the definitions of our constructed variables are common in the literature. The distinctive parts of our analysis rather lie in our methodology. First, we focus on within firm allocation of funds to R&D versus non-R&D investment as opposed to the more common approach that focuses on cross-firm variation. Second and to the best of our knowledge, this paper makes the first attempt at empirically determining the relationship between funding costs (captured by various types of corporate bond spreads) and the allocation of investment between R&D and non-R&D activities. Our within-firm focus here is critical as it allows us to control for firm level fixed effects that can change across time (and that perhaps could be related to funding costs) and thus could not be accounted for with standard empirical models with time and firm fixed effects.
Our initial results, obtained from a difference general method of moments (GMM) dynamic panel estimator, show an increase (decrease) in the share of R&D investment when credit spreads increase (decrease). Consistent with our model's optimality conditions, we find that the reallocation of funds from non-R&D activity to R&D activity is much stronger for firms with a high share of R&D compared to low R&D firms whose reallocation of investment is instead more sensitive to changes in their financial constraints.
Next, we incorporate R&D incentives into our analysis by collecting data compiled by two separate surveys. The degree of external grants and loans are obtained from the National Science Foundation, Business Research and Development and Innovation Survey (BRDIS) and R&D tax credits are from the Internal Revenue Service's, Statistics of Income (SIO) Statistics on Corporation Research Credit. Both sets of data are available at the sector level and annual frequency. We add these data to our firm level dataset by matching the firms' sectors with those in the two surveys. Classify firms as low/high tax credit and low/high external support, we find, consistent with our theoretical prediction that firms in sectors that receive high external support but low tax credits are also the ones whose share of R&D investment in total investment increases (decreases) the most when funding costs rise (drop). Our empirical findings are robust to alternative definitions of funding costs, the dependent variable, and external support and tax credit.
Our findings have implications for the effects of credit conditions (and the policies that create these conditions) on volatility and growth of economies. During easy credit conditions, for example, the composition of investment shifts towards non-R&D activities that may also be more volatile due to higher interest rate sensitivity. By contrast, while economic activity is low during a credit tightening, there is also less volatility since R&D activities, the more robust form of investment, has a higher share. The distortionary effects of R&D incentives that we identify imply that while government tax credits decrease the robustness of R&D spending and render these activities more similar to non-R&D activities, external grants and loans increase the robustness of R&D. Our results also predict and imply that R&D spending, a crucial determinant of long-run growth of economies and economic productivity, may be insulated from short-run credit conditions. This insulation, though, comes at price, as R&D activities are cross-subsidized with non-R&D activities. This in turn could imply that an economy with a high share of R&D in production could potentially experience higher volatility in unskilled labor and more general output markets.
There is a vast and long-standing literature on the determinants of R&D and non-R&D investment behavior of firms. There is an agreement in this literature that the Modigliani-Miller theorem is violated for investment decisions of firms and as their optimal decisions hinge on their capital structure and borrowing constraints. Empirical studies such as Fazzari et al. (1988) , Kaplan and Zingales (1997) , Fazzari et al. (2000) study the role of these financial factors for non-R&D investment decisions. Hall (1992) , Hall (2002) , Himmelberg and Petersen (1994) , Hall and Lerner (2010) , Brown et al. (2009) and Brown and Petersen (2011) do the same by focusing on R&D financing.
3 The latter two studies also provide evidence that equity finance and liquidity are increasingly used to smooth out the fluctuations in R&D spending of manufacturing firms. 4 Our choice of firm-specific variables, including those that measure financial constraints and liquidity, is informed by these seminal papers. Unlike the aforementioned and other studies in the literature, our paper makes a first attempt at analyzing the intra-firm allocation of investment between R&D and non-R&D activities and determining how this allocation depends on credit conditions and R&D incentives.
3 Hall and Lerner (2010) offer a detailed discussion of financing of R&D and an excellent review of the literature related to financing constraints in R&D investment. 4 There have also been recent attempts at understanding the role of funding costs for R&D spending in a general equilibrium analysis. Caggese and Perez-Orive (2017) , for example, show that the interaction between intangible capital, that is used for R&D, and interest-rates can play a role in productivity and output growth by altering asset prices. In particular, a decrease in interest rates increases the price of intangible assets and reduces the ability of firms to buy intangible capital by reducing the accumulation of savings. Dotting and Perotti (2015) show that intangible capital is mostly financed by equity because it is hard to collateralize. Therefore, lower demand for external finance results in a decrease in interest rates.
In the absence of credit constraints, the optimal decision about whether to invest in innovative investment or capital investment depends on the opportunity cost of investment over the business cycle. Since the opportunity cost of reallocating resources towards innovative investment is smaller in recessions, the usual observation is that R&D is countercyclical over the business cycle Saint-Paul, 1998, Aghion et al, 2012) . However, several papers demonstrate that when financing constraints are binding, R&D investment of a constrained firm may fall during recessions, implying a procyclical R&D investment (Aghion et al, 2005 (Aghion et al, , 2012 .
Other studies reach a similar conclusion. Himmelberg and Petersen (1994) , and Hall and Lerner (2010) , for example, show that R&D could be procyclical due to liquidity effects. The procyclicality of R&D in Barlevy (2007) is due to the fact that labor costs are easier to finance during expansions. Given the stylized fact that borrowing spreads are countercyclical, our empirical results imply, consistent with the latter set of studies, that R&D investment is procyclical. In addition, however, we find that R&D's share in total investment is countercyclical and that this result is reinforced by research grants/subsidies. This finding is consistent with Brown and Petersen (2015) which shows that firms spend more cash to protect their R&D investment relative to non-R&D investment due to larger adjustment cost associated with R&D. In our theoretical framework, the countercyclicality of R&D share is rather driven by the distortionary effects of R&D incentives.
Despite the general notion that there is an essential role for public policies given the positive externalities associated with R&D, evidence for the effectiveness of these policies is mixed. While studies such as Hall (1993) , Hines (1993) , Bloom et al. (2002) and Wilson (2009) find that government tax credits (the primary form of government R&D incentive) are ineffective in increasing R&D spending in the short-term, findings of Rao (2016) and Thomson (2015) indicate otherwise. By contrast, the literature (e.g. Howell, 2017; Neicu et al., 2014 , Lerner, 2000 , Wallsten, 2000 , Hellmann and Puri 2000 Sørensen 2007 ) on the effects of R&D subsidies (government and private) and the external funding of R&D (especially with venture capital) resoundingly agree that subsides and external funding spur R&D, and have positive outcomes for firms' performance. Unlike the studies mentioned above, we study the distortionary effects of tax credits and subsidies jointly and we find that while tax credits increase the cross-subsidization of R&D with non-R&D investment when credit is constrained, subsidies decrease the strength of this mechanism.
A Partial Equilibrium Framework with R&D Investment
In this section we build a partial equilibrium model with R&D investment to illustrate the effects of R&D incentives on the investment allocation decisions of firms.
Model Overview
The model features two imperfectly competitive intermediate good producers that maximize a stream of dividends by choosing how much labor to hire and how much to investment.
The output of the two firms is combined into a single wholesale good by a perfectly competitive final good producer. While both firms can choose to accumulate physical capital, only one of the firms, hereafter referred to as the R&D firm, can do R&D investment. The R&D firm receives subsidies that reduces its borrowing and labor costs. These subsidies are the source of distortions in the model. The other firm, i.e., non-R&D firm, is not subsidized. Investment expenditures for both firms are externally financed at an exogenously determined interest rate. The relationship between the firms' investment decisions and this interest rate receives the spotlight throughout our analysis.
In the second half of this section, as an alternative to investment, we allow the stock of R&D to accumulate with labor. Using this definition of the technological process, we then derive the relationship between, the two firms' relative demand for labor and the wage gap between skilled and unskilled labor.
The intermediate and final good producers
The R&D firm chooses the amount of labor, investment and dividend payments to maximize the following function: 
The formulation above is the generalized version of Romer (1990) 
where the parameters  and  account for the "standing on shoulders" and the "stepping on toes" effects associated with R&D (with  <1 implying the presence of "stepping on toes" effects).  represents the depreciation rate of physical capital.
Notice here that the production function in equation (2) 
Unlike the R&D firm, the non-R&D firm invests only in physical capital. In so doing, it faces the same borrowing rate that the R&D firm faces. It too is a price-taker in the labor market and it produces output according to a similar production function:
Here we assume that the parameters governing the production function are the same as those for the R&D firm, the stock of human capital is time-invariant, and that there are no technological spillovers from the R&D firm to the non R&D firm. 
The cost minimization problem of the final good producer, assuming that the final good is the numeraire, produces the following expressions for the price of the two intermediate goods:
Interest rate -investment relationship
To solve our model, we substitute the expressions for prices in their respective maximization problems, and derive the following first order conditions that describe the demand for labor, and fixed and R&D investment for the R&D firm, respectively:
For the non-R&D firm the first order conditions describe labor and non-R&D investment demand only:
As mentioned above, the primary insight we want to extract from our model is the compositional effects of interest rates on investment behavior. This information can be extracted in two ways from first order conditions above: 1) By solving for the ratio of R&D investment to non-R&D investment 2) by solving for the ratio of R&D investment to total investment within the R&D firm. These two ratios are given by,
The inferences from the two ratios are similar. By construction the proportion of R&D investment within the firm is positively related to the rate at which R&D investment increases the R&D stock.
Similarly, the share of non-R&D investment increases as its share of capital in the production function increases. In other words, less capital-intensive firms that rely more on their stock of knowledge or human capital, as expected, have a higher share of R&D investment than non-R&D investment. The relative share of R&D investment also increases with government subsidies.
Specifically, the two ratios in equations (15) and (16) (15) and (16) to derive the interest rate sensitivity of the two ratios as follows:
Equations (17) and (18) percentage increase in the unit costs of R&D investment. Simply put, the cost advantages of R&D investment dissipate as interest rates rise and R&D's share in overall investment decreases. The two counteracting effects of R&D subsidies on the interest rate sensitivity of investment allocation mentioned above are magnified when R&D's share is high, the share of non-R&D investment is low in the production function, and when the stepping on toes effects are low ( is high).
So far, we've scrutinized the investment allocation decisions within the R&D firm. Next, we extend our analysis and we make a comparison across the two firms and across the different types of investment. We do so by measuring two ratios:
Total R&D firm to non-R&D firm investment ratio,
and the R&D investment to total non-R&D investment ratio,
The share parameter,  , in equation (19) captures scale effects. Specifically, as the share of R&D firm's output in the production of the final good increases so does the share of its total investment and R&D investment. Taking the derivatives of the two ratios with respect to interest rate, t R , 1 , produces expressions that are similar to the sensitivity expression in equation (17) as they also contain the two counteracting effects of subsidies:
These partial derivatives, too, indicate that if R&D investments are subsidized mostly through lower interest rates, the share of R&D investments and the total investment expenditures of firms with R&D activity increases in an economy when borrowing costs increase. These conclusions are reversed if R&D incentives are mostly through tax credits.
Wage gap -labor demand relationship
As mentioned earlier, an alternative form of subsidization works through labor incentives.
Further, a stylized fact about R&D activity is that it is a labor-intensive process. To incorporate these aspects of technology we first modify the evolution of R&D stock as shown below so that the R&D firm hires skill labor to enhance its stock of knowledge and human capital, instead of investing in research efforts to do so. 
where l s is the subsidy parameter. These subsidies can be thought of as the payroll tax credits that firms receive from the government or external grants/loans that partially finance the firm's research hires.
The optimality conditions of the two firms can be combined to derive the relative demand for skilled labor within the R&D firm and the relative demand for labor across the two firms as follows:
In this setup we define the skilled-unskilled labor wage gap as
Since there are no counteracting forms of incentives in this setup, it is simpler/cleaner to illustrate the impact of changes in wage gap on the relative demand for labor as follows, by deriving the percent changes in the expressions above.
The first inference here is that an increase in * w causes a drop in the share of skilled labor within the R&D firm and a drop in the share of labor force hired by the R&D firm. More critically, the strength of this channel is positively related to the level of subsidies. The reason is that at higher levels of l s , as we observed with higher levels of investment tax credit, the relative cost advantages of the subsidy diminishes as skilled-labor wages rise and thus the percent share of skilled labor in the R&D firm, and in the industry, falls.
We should note here that in our model the R&D firm does not incur any costs when adjusting investment and labor or switching between the different types of investment and labor.
Although it is possible to extend our analysis to incorporate these realistic aspects of funding, the distortionary effects of R&D subsidies would be similar, albeit smaller in magnitude. To avoid confounding our analysis in this section, we do not try to draw quantitative inferences from model.
Instead, we conduct an empirical analysis to test the validity of some predictions from our model and to measure the strength of the relationships we identified. We turn to this topic next.
An Empirical Analysis
Our theoretical predictions above are related to the composition of investment and labor.
In this section, we solely investigate the intra-firm allocation of spending between non-R&D investment and R&D investment since data on the labor composition of a wide group of firms are not readily available. Given the dynamic panel estimator that we will be using, focusing on intrafirm allocation of investment is the most effective way for us to control for any unobserved firm specific determinants of the sensitivity to borrowing costs. We begin by describing this methodology.
Methodology
To measure the within firm allocation of investment, we compute the relative growth rate
where it RDG and it NRDIG denote the growth rate of firm i's R&D and non-R&D investment expenditures at time t, respectively, and the year-over-year growth rates are measured as logdifferences.
it RDG R _ is the main dependent variable in most of our estimations. Our main independent variables are average corporate bond spreads, denoted by t BS , in the market that capture the terms of borrowing for different types of firms. The coefficient of this variable receives the spotlight throughout our analysis as it indicates how the allocation of spending between R&D and non-R&D investment is affected by credit market conditions.
In addition to this macroeconomic variable, we also include the growth rate of various firmspecific financial ratios/indices that are commonly associated with investment behavior. Out of these variables, variables that measure a firm's reliance on external finance is of particular interest to us as it is reasonable to assume that firms with a larger degree of external finance would be more sensitive to funding costs. To account for this potential mechanism, we also interact our measure of external finance dependence (hereafter, financial constraints) with funding costs and include it in our empirical model. The remaining firm specific variables are firms' sales growth and the growth rate of financial ratios that measure firms' liquidity and the profitability of their investment.
Growth rates in a given quarter are measured as percentage point changes over the same quarter of the previous year. We stack the firm-specific control variables in vector it C and include it in the following dynamic panel model: behavior. This allows us to account for the cyclical behavior of investment, the persistence of borrowing spreads and the timing differences between actual implementation of investment and its funding.
We estimate the dynamic panel model in equation (30) by using the Arellano and Bover (1995) difference GMM methodology. 6 We do so because the methodology has several advantages. First, our panel has a much smaller time dimension compared to its cross-sectional dimension and the methodology is designed for such datasets. Second, it minimizes endogeneity problems by instrumenting independent variables that are not strictly exogenous with the lags of their first differences. 7 Finally, the methodology accounts for potential heteroskedasticity and serially correlation in the error terms, and fixed and random effects in the panel.
The more critical aspect of the methodology is that by measuring the growth rate of the two investment types in relative terms, it controls for any time-varying firm-specific factors that may be symmetrically related to R&D and non-R&D investment growth and borrowing spreads in the economy. These time-varying effects cannot be picked up with usual applications with timeinvariant firm fixed effects and these fixed effects would get dropped out from our difference GMM estimator. The way we construct our dependent variable, therefore, not only allows us to investigate the determinants of relative R&D spending but it also allows us to minimize the risks of an omitted variables bias in doing so.
Data
The quarterly firm level data that we use in our analysis are obtained from the COMPUSTAT (North America) database for the 2010Q1-2015:Q4 period. The main reason we choose this period is to exclude the confounding effects of the Global Financial Crisis and the 6 We follow the steps in Roodman (2009) to apply this methodology. 7 We use the first four lags of the right hand side variables in this step.
volatile period leading up to it. The definitions of the firm-specific variables in our sample are presented in Appendix A.
In constructing our main dependent variable, relative R&D investment growth, we use a quarterly measure of research and development expenses and subtract net total investment expenditures from this. R&D expenditures represent all costs incurred during a given quarter that relate to the development of new products or services. Net total investment is not reported as a separate variable in COMPUSTAT. To construct this variable, we follow the common practice and add capital expenditures, inventory investment, acquisitions and subtract sale of property and investments, and changes in marketable securities, cash equivalents and miscellaneous investment items from this total. It should be noted here that we are using a broader measure than capital expenditures as our measure includes both short term and long term investment based on firms'
statements. 8 The items that are used to construct total investment are reported quarterly as year-todate variables in the COMPUSTAT database. To obtain quarterly growth rates of investment, we measure the quarterly changes in the reported annual values of the variables mentioned above.
Our main independent variables measure borrowing spreads and the degree of financial constraints. To capture funding costs for firms we use three types of corporate bond spreads: BofA Merrill Lynch US Corporate Option-Adjusted Spread in securities with a rating of AAA, BBB and CCC (or below). The spreads are measured as the difference between the index of all the bonds in a given rating category and a spot Treasury curve. We choose the ratings AAA, BBB and CCC or below to cover the broad spectrum of funding spreads and to check for the robustness of our results.
To simplify the discussion of our results we often refer to borrowing spreads as funding costs below.
Our measure of financial constraints is the Kaplan-Zingales (KZ) index. This index, in addition to financial leverage, includes firm-specific characteristics such as dividend payments and cash flow. There is recent evidence indicating that firms increasingly rely on external funding for R&D investments, and that the external financial constraints that they face are not fully captured by their leverage. 9 In this sense, using the KZ index is the most comprehensive/accurate way to approximate external funding constraints. Although it is not clear how financial constraints impact the allocation of funds between R&D expenditures and investment, it is common consensus that it can negatively affect investment spending. There are three reasons for this. First, financially constrained firms also face liquidity constraints or have a worsened outlook. Therefore, they have difficulty with taking advantage of investment opportunities. Second, these firms' management might have lower incentives to invest because the benefits of the investment goes to bondholders, not to the shareholders, which is also referred to as the debt overhang problem. Third, the negative relationship could be due to an overinvestment problem in which the managers of firms with good growth opportunities might find it harder to invest because as debt accumulates it hurts the firm's value. A negative relationship between financial constraints and future investment is, therefore, a common finding. The distinctive feature of our methodology is that it helps us determine whether the potential negative effects of funding costs on investment apply differently to R&D and non-R&D investment.
The other standard components of empirical models of investment behavior are measures of profitability and liquidity. We incorporate the former by using the Tobin's Q and sales-to-total-assets ratio that gauge potential profits from future investments. For the liquidity measure we use the cash-and-short-term-investments-to-total-assets ratio. These variables are available at the quarterly frequency and they are also defined in Appendix A.
Turning to R&D incentives, we use two data sources to measure the degree of R&D expenditures paid by others to total domestic R&D. 10 To gauge the significance of tax credits in a given sector we use the ratio of current-year credit for increasing research activities to total domestic R&D expenditures as our baseline measure of R&D tax incentives.
11
To combine the sector level subsidization dataset with our firm-level dataset, we assign a sector's ratios (mentioned above) to the firms that are in that sector. In so doing, we match the North American Industry Classification System (NAICS) identifier for each firm with the sector in BRDIS and ISO. In our analysis of the impact of R&D support, we use the sector level data mentioned above to classify firms into groups and we investigate whether the theoretical predictions from the previous section are accurate. To do so, we designate firms as low (high) R&D funding if they are in a sector that is in the bottom (top) 40 percent in terms of the R&D 10 The database also reports the amount of R&D funding by foreigners and by the government. These figures are not the primary source R&D support for most sectors and thus we do not use them as our baseline measure. We do, however, use these variables in our sensitivity analyses. 11 SIO also has alternative measures of tax credit incentives that we use in our sensitivity analysis. funding ratio defined above. We then do the same by using the tax credit ratio and classify firms into high and low tax credit groups.
12
Our sample includes 20,652 firms that engage in R&D activity. The panel is unbalanced as data for some firms are not available for each quarter in our sample period. Some of the characteristics of these firms are displayed in Table 1 . During our sample period, the growth rate of R&D expenditures has outpaced the growth of non-R&D investment although it is 8.6 percent of non-R&D investment on average. The subsidization statistics indicate that external funding of R&D is the primary way in which R&D activity is subsidized. Specifically, while external funds constitute 18.8 percent of total domestic R&D expenditures, tax credits are only 3.3 percent of this item. Below we will test our main theoretical prediction that firms in sectors with high R&D funding and low tax credits (hereafter, HFLC firms) are less sensitive to funding costs. It is, therefore, useful at this point to compare some of the characteristics of HFLC firms with the whole sample and those that receive low funding and high tax credit (hereafter, LFHC firms). We observe in Table 1 that HFLC firms have increased their R&D expenditures more than the rest of the firms in our sample and the LFHC firms, and that their R&D expenditures, relative to their investment, is large compared to other firms. These observations are consistent with the predictions that we made in the previous section. HFLC firms are also smaller in size, more financially constrained, more liquid and have higher profit opportunities (as indicated by Tobin's Q) compared to the rest of the firms. It is, therefore, critical to control for these factors when identifying the independent effects of funding costs on relative R&D investment.
As displayed in the bottom panel of Table 1 , there are substantial differences between the different bond spreads (the average values across the sample period). Since we cannot directly observe the bond rating for each firm in our sample, we check the robustness of our results to using different bond ratings throughout our analysis.
Initial results: Funding costs and the share of R&D spending
Our initial results, obtained by estimating equation (30), are displayed in Table 2 . 13 This result provides support for one of the theoretical mechanisms that we identified in equation (17). If R&D subsidization works mostly through external funding support (a high  ) than there is a positive relationship between the changes in funding costs and the relative share of R&D spending. This is also consistent with the descriptive statistics in Table 1 showing that R&D's external funding is much larger than the tax incentives it receives.
Turning to financial constraints, we find that an increase in a firms' financial constraints (measured by an increase in its KZ index) affects its non-R&D investment disproportionately, causing its share to drop. Furthermore, this impact of financial constraints is stronger when funding costs are increasing as it can be inferred from the interactive term coefficients. The coefficients of the remaining variables indicate that if a firm has higher profit opportunities from investment, higher liquidity and higher sales growth, it increases the share of non-R&D investment.
The statistics reported in the bottom panel of Table 2 , the p-values and z-values from
Hansen and AR (2) tests, indicate that instruments as a group are valid and exogenous, and that there is no evidence for second-order serial correlation in the error term. This is also true for all the other estimations in our paper.
As indicated earlier, the reason we use general bond indices instead of firm level borrowing spreads is that the latter are not available for the set of firms we have in our sample. It is therefore useful to check whether inferences obtained from alternative bond indices are similar. While our baseline measures of credit spreads give us a sense of robustness, the three indices do not exhaust the list of credit spreads that are available. In Table 3 we report the main coefficients that we obtain from equation (30) when we use a broader set of bond indices. The results, similar to those in Table 2 , indicate a positive and significant relationship between the share of R&D spending, and funding costs and financial constraints. 14 Notice that it is not straightforward to compare the coefficient values across the different bond types as their mean values and standard deviations are considerably different. We thus refrain from doing so since it is not the primary objective of our analysis. The full estimation results are reported in Appendix B.
14 The signs and significance of the remaining coefficient values are similar and they are not reported for brevity.
The general inference so far is that the share of R&D expenditures in total investment increases when there is a tightening in credit conditions. This, however, does not allow us to determine how the two types of investment activity are individually related to funding costs. The reason we find positive coefficients in Table 2 , for example, could be that both R&D and non-R&D spending are positively related to credit spreads and that R&D spending is more sensitive.
To further explore the sources of our findings in Table 2 and to rule out this unrealistic scenario, we include the growth of R&D spending and non-R&D spending separately as the independent variable in equation (30). This approach also allows us to test the theoretical relationship between R&D and non-R&D spending and funding costs across firms displayed in equation (22), as opposed to the within firm allocation of investment. The results in Table 4 show that both types of investment activities are negatively related to credit spreads. Comparing the magnitude of the funding cost coefficients, however, indicates that non-R&D is much more sensitive to credit conditions. This disparity between sensitivities holds for the other independent variables as well.
Specifically, we find that R&D spending is not sensitive to firms' financial constraints, liquidity and the Tobin's Q. While the coefficients for sales growth and the interactive variable are significant in the R&D estimations, these are much smaller compared to the corresponding coefficients obtained from the estimations with non-R&D spending.
As a final exercise we assess how our inferences are related to the degree of R&D activity by dividing the firms with R&D activity into two groups: high and low R&D. In a given quarter, a firm is designated as high R&D if its R&D investment as a share of its total investment in the previous quarter is greater than the average R&D-to-total-investment ratio measured across all the R&D firms in the previous quarter. Otherwise, the firm is designated as low R&D. The results obtained from these alternative samples, by using the baseline definition of the dependent variable, are reported in Table 5 . The striking observation here is that the allocation of funds to R&D investment (away from other investment activities) is only significant for high R&D firms and that this mechanism is stronger compared to the baseline results. For low R&D firms, we find that the changes in financial constraints instead impact the allocation of funds between R&D and non-R&D investment. This impact, too, is much larger compared to the baseline results. Overall, these findings imply that high R&D firms' reallocation of funds from non-R&D activity to R&D activity when funding costs rise is much stronger compared to low R&D firms whose allocation of funds is instead more sensitive to changes in their financial constraints.
The impact of R&D support
In the first half of the paper we predicted that the effect of borrowing costs on the allocation of investment between R&D and non-R&D depends on the type of R&D incentives that a firm receives. If these incentives are mostly through external funding support, a credit tightening increases the share of R&D spending. By contrast, the share of R&D decreases for a firm that receives incentives mostly through tax breaks. The opposite conclusions hold under an easing of credit conditions. To test this prediction, we estimate our baseline model by using data for firms in sectors receiving high level of external funding and low levels of tax credits (HFLC firms). The reason we use this approach is that the R&D incentives data, as described above, are only available at the sector level and does not span the entire period that our firm-level dataset covers. Therefore, there is no one to one mapping between firms and the amount of R&D support that they receive.
It is, however, reasonable to expect that if our theoretical prediction is sound, there should be a positive relationship between funding costs and the share of R&D for firms in the restricted sample that we use in this section.
The results in Table 6 show that this is true. Compared to the whole sample, HFLC firms have larger funding cost coefficients. They, therefore, experience a more substantial increase (decrease) in the share of their R&D investment, relative to non-R&D investment, when there is an increase (decrease) in funding costs. 15 The larger interactive variable coefficient for the restricted sample further suggests that this disproportionate effect of funding costs is amplified for financially constrained firms. The financial constraint coefficient by itself, however, is smaller in the restricted sample thus suggesting that financial constraints cause a sharper increase in the R&D spending share of HFLC firms only if credit conditions are tighter. Turning to the remaining firmspecific variable coefficients, we observe that HFLC firms' future profit opportunities, liquidity and sales growth have a smaller impact, albeit not substantially different, on the allocation of investment between R&D and non R&D.
In what follows, we describe and report results from various tests of sensitivity and robustness that corroborate our findings on the effects of R&D support. The results from these tests are all reported on Table 7 . To simplify the demonstration, we only report results from the estimations with medium yield bonds, and we only include the coefficients of the three major variables that we've focused on so far. It should be noted, however, that the remaining coefficients are similar to those in our baseline estimations in terms of sign and significance, and we obtain similar inferences with high and low yield bonds. To facilitate a comparison, we also include our baseline results on the first two rows of the table. As a first test, we investigate firms in sectors that receive low support and high tax incentives (LFHC firms) and thus firms that are diametrically opposed to the ones we considered above. The results indicate, consistent with our theoretical prediction that, the increase in these firms' R&D spending share in response to an increase in funding costs is not as sharp as the HFLC firms. The reinforcing effects of financial constraints are also smaller for this group.
In the next 4 rows, we report estimation results based on alternative definitions of external funding support (government and foreign funding of domestic R&D investment) and tax incentives (total tax credit / qualified expenses and regular credit / qualified regular credit expenses). Here, One factor that we have not considered in our comparisons of the coefficients is the standard deviation of our main independent variables. If there is a considerable difference in the variation of these variables across the two samples we investigate (the baseline sample and the restricted sample), our comparison can be inaccurate as the coefficients of the variables with higher variation would be smaller. To account for this potential shortcoming, we standardize our variables so that the coefficients that we obtain measure the response of relative R&D spending growth to a one-standard-deviation change in the right hand variable. The results from this test also produces larger coefficients for funding costs and the interactive variable in the restricted sample. Simply put, HFLC firms show a larger shift towards R&D spending during a credit tightening compared to the full sample.
Conclusion
This paper demonstrates that firms cross-subsidize their R&D investments with their non-R&D investment expenditures when external funding costs increase. This mechanism is reinforced by R&D incentives that are in the form of grants and subsidized loans, and it is weakened by tax credits to R&D. The reason is that R&D expenditures of firms receiving a high level of grants and low interest loans become less sensitive to market funding costs. Firms that receive incentives in the form of tax credits, by contrast, decrease their share of R&D spending when funding costs rise because they have low unit R&D costs (due to the tax incentives) and an increase in interest rates has larger negative impact on their R&D spending compared to their non-R&D spending. We find empirical evidence for these theoretical predictions by using firm-level financial and sector level R&D incentives data, and using this in a unique identification strategy that focuses on the withinfirm allocation of investment expenditures between R&D and non-R&D activities.
One projection from our analysis is that when a credit tightening slows economic activity it also puts it on a more stable footing as firms shift their focus to less volatile activities that are more conducive to economic growth. Conversely, the brunt of a credit easing finances more volatile activities and thus makes the economy potentially less stable going forward. It would be interesting to test this projection by using firm-level and regional/cross-country data. Specifically, one could determine whether firms engaging in R&D activities face lower volatility in their performance and fundamentals during and after credit tightening episodes compared to firms that do not report R&D spending. One could then determine whether tax credits weaken and grants/subsidies reinforce this mechanism by investigating regional data. In other words, are regions with high tax incentives to R&D much more volatile after a period of high borrowing spreads compared to regions receiving grants/subsidies? (0.000)*** (0.000)*** (0.000)*** (0.000)*** (0.000)*** (0.000)*** (0.000)*** (0.000)*** (0.000)*** (0.000)*** (0.000)*** (0.000)*** (0.000)*** (0.000)*** (0.000)*** (0.000)*** (0.000)*** (0.000)*** (0.000)*** (0.000)*** (30) for firms in sectors that receive a high level of R&D subsidies and a low level of tax credits (HFLC firms). Firms are designated as high subsidy if they are in a sector that is in the top 40 percent of all sectors in terms of the total external R&D funding ratios. Similarly firms are classified into the low tax credit group if their sector's tax credit ratio is in the bottom 40 percent. For the R&D funding ratio we use the ratio of total domestic R&D expenditures paid by others to total domestic R&D. For the tax credit ratio we use the ratio of current-year credit for increasing research activities to total domestic R&D expenditures. The numbers in parentheses are the p-values from tests that determine the joint significance of the coefficients. *, **, *** significant at 10%, 5%, 1%, respectively. The statistics reported for the Hansen and AR2 tests are the p-values and zvalues, respectively. (0.000)*** (0.000)*** (0.000)*** (0.000)*** (0.000)*** (0.000)*** 
Appendix B. Full estimation results with alternative bond ratings

